5 In summary, while Berberine shows promise, experts advocate for regulated clinical use, appropriate patient selection, and more rigorous studies to validate its safety and efficacy across broader populations
it was studied by Novo Nordisk and later Helsinn Therapeutics, including a Phase II trial for postoperative ileus, but development was discontinued for lack of efficacy
Their model achieved AUROCs of 0.910, 0.890, and 0.700 for respiratory failure, circulatory failure, and acute kidney injury, respectively, underscoring the value of sequential modeling for dynamic clinical decision support
Semaglutide has gained attention in recent years as a key treatment option for type 2 diabetes, but how does it compare to other medications
Perhaps you are seeing the first signs of fine lines or a few stubborn dark spots that won't seem to fade
When the pattern kept showing up in study after study, researchers started asking a question that could redefine how we think about metabolic health and addiction: what if losing the weight and losing the drinking arent separate effects at all